Harvard Apparatus Regenerative Technology Inc Receivables Turnover Ratio (BSTG), from the first quarter 2026 to the first quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Harvard Apparatus Regenerative Technology Inc   (BSTG)
 

Harvard Apparatus Regenerative Technology Inc Accounts Receivables Turnover Ratio from the first quarter 2026 to the first quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Harvard Apparatus Regenerative Technology Inc 's ability to collect accounts receivable sequentially worsen to 88.5, indicating more challenging environment then in the fourth quarter 2025, but still, it is a far cry from any concerns. Average collection period, for Harvard Apparatus Regenerative Technology Inc 's accounts receivable remained unchanged at 4 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 16 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 135, from overall ranking in the fourth quarter 2025 at 2428.

What is Receivable Turnover Ratio?
What is Harvard Apparatus Regenerative Technology Inc Selling?


What is Receivable Turnover Ratio?





BSTG Receivables Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Receivable Change 300 % -93.07 % 200 % - -42.86 %
Y / Y Revenue Change 402.22 % -15.12 % 108.47 % 466.07 % -21.05 %
Receivable Turnover Ratio (TTM) 88.5 100.57 12.23 11.27 7.08
BSTG's Total Ranking # 135 # 2428 # 893 # 2599 # 2672
Accounts Receivable average collection period days 4 4 30 32 52
Seq. Receivable Change 0 % 433.33 % -40 % 25 % -98.27 %
Seq. Revenue Change 3.2 % 78.05 % -61.2 % 604.44 % -82.56 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 7
Healthcare Sector # 17
Overall Market # 135

Receivable Turnover Ratio Statistics
High Average Low
100.57 45.86 7.08
(Dec 31 2025)   (Mar 31 2025)






Financial Statements
Harvard Apparatus Regenerative Technology Inc 's Accounts Receivable $ 0 Millions Visit BSTG's Balance sheet
Harvard Apparatus Regenerative Technology Inc 's Sales TTM $ 1 Millions Visit BSTG's Income Statement
Sources of BSTG's Revenues Visit BSTG's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BSTG's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BSTG's Growth Rates BSTG's Roa BSTG's Inventory Turnover Ratio BSTG's Dividend Comparisons
BSTG's Profitability Ratios BSTG's Roi BSTG's Asset Turnover Ratio BSTG's Dividend Growth
BSTG's Valuation Ratios BSTG's Roe BSTG's Financial Strength Ratios BSTG's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Receivable at quarter ending Mar 31 2026
Prime Medicine Inc   134.47 $ 4.034  Millions$ 0.030  Millions
Earth Science Tech Inc   127.94 $ 33.712  Millions$ 0.263  Millions
Lenz Therapeutics Inc   124.93 $ 20.989  Millions$ 0.168  Millions
Agape Atp Corporation  123.42 $ 1.509  Millions$ 0.012  Millions
Assembly Biosciences Inc   121.69 $ 71.097  Millions$ 0.584  Millions
Bridgebio Oncology Therapeutics Inc   114.95 $ 15.288  Millions$ 0.133  Millions
Harvard Apparatus Regenerative Technology Inc   88.50 $ 0.885  Millions$ 0.010  Millions
Zeo Scientifix Inc   74.53 $ 6.987  Millions$ 0.094  Millions
Airsculpt Technologies Inc   69.52 $ 151.836  Millions$ 2.184  Millions
Sbc Medical Group Holdings Incorporated  64.95 $ 167.536  Millions$ 2.579  Millions
Arrowhead Pharmaceuticals Inc   63.74 $ 622.009  Millions$ 9.758  Millions
Hims and Hers Health Inc   63.35 $ 2,369.476  Millions$ 37.405  Millions
Spero Therapeutics Inc   59.36 $ 61.186  Millions$ 1.031  Millions
Humacyte Inc   58.59 $ 34.376  Millions$ 0.587  Millions
Aim Immunotech Inc   53.71 $ 0.094  Millions$ 0.002  Millions
Brookdale Senior Living Inc   49.21 $ 3,145.058  Millions$ 63.914  Millions
Fortrea Holdings Inc   44.31 $ 2,708.600  Millions$ 61.125  Millions
National Vision Holdings Inc   41.80 $ 2,021.044  Millions$ 48.351  Millions
Metagenomi Therapeutics Inc   41.78 $ 22.331  Millions$ 0.535  Millions
Mangoceuticals Inc   41.34 $ 0.415  Millions$ 0.010  Millions
Nature s Sunshine Products inc   39.69 $ 489.104  Millions$ 12.324  Millions
Lifevantage Corp  38.34 $ 193.618  Millions$ 5.050  Millions
Longduoduo Co Ltd  35.04 $ 2.132  Millions$ 0.061  Millions
Innovative Eyewear Inc   33.59 $ 2.981  Millions$ 0.089  Millions
Electrocore Inc   32.90 $ 34.458  Millions$ 1.047  Millions
U S Physical Therapy Inc  30.94 $ 795.488  Millions$ 25.708  Millions
Innovage Holding Corp   30.93 $ 949.172  Millions$ 30.688  Millions
Invo Fertility Inc   29.40 $ 7.219  Millions$ 0.246  Millions
Lineage Cell Therapeutics Inc   28.42 $ 14.779  Millions$ 0.520  Millions
Meiragtx Holdings Plc  28.01 $ 79.758  Millions$ 2.848  Millions

Date modified: 2026-08-29T17:25:12+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.